{
  "title": "Ocugen's COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results of COVAXIN, Demonstrates Efficacy of 81%",
  "link": "https://news.google.com/__i/rss/rd/articles/CBMizQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMS8wMy8wMy8yMTg2MTc4LzAvZW4vT2N1Z2VuLXMtQ09WSUQtMTktVmFjY2luZS1Dby1EZXZlbG9wbWVudC1QYXJ0bmVyLUJoYXJhdC1CaW90ZWNoLXNoYXJlcy1QaGFzZS0zLUludGVyaW0tUmVzdWx0cy1vZi1DT1ZBWElOLURlbW9uc3RyYXRlcy1FZmZpY2FjeS1vZi04MS5odG1s0gEA?oc=5",
  "pubDate": "Wed, 03 Mar 2021 13:00:00 GMT",
  "source": "GlobeNewswire",
  "content": "<ol><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMizQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMS8wMy8wMy8yMTg2MTc4LzAvZW4vT2N1Z2VuLXMtQ09WSUQtMTktVmFjY2luZS1Dby1EZXZlbG9wbWVudC1QYXJ0bmVyLUJoYXJhdC1CaW90ZWNoLXNoYXJlcy1QaGFzZS0zLUludGVyaW0tUmVzdWx0cy1vZi1DT1ZBWElOLURlbW9uc3RyYXRlcy1FZmZpY2FjeS1vZi04MS5odG1s0gEA?oc=5\" target=\"_blank\">Ocugen's COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results of COVAXIN, Demonstrates Efficacy of 81%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GlobeNewswire</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMibmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTAzLTAzL2NyaXRpY2l6ZWQtaW5kaWFuLXZhY2NpbmUtYWxyZWFkeS1pbi11c2UtZm91bmQtODEtZWZmZWN0aXZl0gEA?oc=5\" target=\"_blank\">Criticized Indian Vaccine Already in Use Found 81% Effective</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiRmh0dHBzOi8vbmV3cy55YWhvby5jb20vaW5kaWFzLWJoYXJhdC1iaW90ZWNoLXNheXMtY292aWQtMTEzNjA5MTE3Lmh0bWzSAU5odHRwczovL25ld3MueWFob28uY29tL2FtcGh0bWwvaW5kaWFzLWJoYXJhdC1iaW90ZWNoLXNheXMtY292aWQtMTEzNjA5MTE3Lmh0bWw?oc=5\" target=\"_blank\">Bharat Biotech's COVID-19 shot 81% effective, Indian firm's interim data shows</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo News</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMigQFodHRwczovL3d3dy5pbmRpYXR2bmV3cy5jb20vbmV3cy9pbmRpYS9jb3ZpZC12YWNjaW5hdGlvbi1ob3ctcG0tbW9kaS1pbnNwaXJlZC1hYWota2ktYmFhdC1vcGluaW9uLXJhamF0LXNoYXJtYS1sYXRlc3QtbmV3cy02ODgzMDTSAYUBaHR0cHM6Ly93d3cuaW5kaWF0dm5ld3MuY29tL2FtcC9uZXdzL2luZGlhL2NvdmlkLXZhY2NpbmF0aW9uLWhvdy1wbS1tb2RpLWluc3BpcmVkLWFhai1raS1iYWF0LW9waW5pb24tcmFqYXQtc2hhcm1hLWxhdGVzdC1uZXdzLTY4ODMwNA?oc=5\" target=\"_blank\">Opinion | Covid vaccination: How Modi inspired</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">India TV News</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiiQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3Rvcnkvb2N1Z2VuLXN0b2NrLXNvYXJzLWFmdGVyLXBhcnRuZXItYmhhcmF0LWJpb3RlY2gtY292aWQtMTktdmFjY2luZS1jYW5kaWRhdGUtc2hvd3MtODEtZWZmaWNhY3ktMjAyMS0wMy0wM9IBjQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL3N0b3J5L29jdWdlbi1zdG9jay1zb2Fycy1hZnRlci1wYXJ0bmVyLWJoYXJhdC1iaW90ZWNoLWNvdmlkLTE5LXZhY2NpbmUtY2FuZGlkYXRlLXNob3dzLTgxLWVmZmljYWN5LTIwMjEtMDMtMDM?oc=5\" target=\"_blank\">Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketWatch</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqcggKImxDQklTU3pvSmMzUnZjbmt0TXpZd1NqNEtFUWpPMFBlTGtvQU1FWVNHSHQ2cnFWRHRFaWxDYUdGeVlYUWdRbWx2ZEdWamFDQjJZV05qYVc1bElITm9iM2R6SURneEpTQmxabVpwWTJGamVTZ0FQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
  "contentSnippet": "Ocugen's COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results of COVAXIN, Demonstrates Efficacy of 81%  GlobeNewswire\nCriticized Indian Vaccine Already in Use Found 81% Effective  Bloomberg\nBharat Biotech's COVID-19 shot 81% effective, Indian firm's interim data shows  Yahoo News\nOpinion | Covid vaccination: How Modi inspired  India TV News\nOcugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy  MarketWatch\nView Full Coverage on Google News",
  "guid": "62afe3fff8f76dc160cbb8328182b850",
  "isoDate": "2021-03-03T13:00:00.000Z",
  "original_created_at": "2021-03-03T13:00:00.000Z",
  "created_at": "2021-03-03T14:55:01.285Z",
  "original_guid": "52781415000142",
  "id": "62afe3fff8f76dc160cbb8328182b850",
  "tags": [
    "GlobeNewswire"
  ],
  "image": "http://www.globenewswire.com/Attachment/LogoDisplay/825438?filename=825438.png&size=1",
  "localize": [
    {
      "locale": "zh",
      "title": "Ocugen的COVID-19疫苗合作开发伙伴Bharat Biotech分享了COVAXIN的3期中期结果，证明疗效达81%。"
    },
    {
      "locale": "zh-Hant",
      "title": "Ocugen的COVID-19疫苗合作開發夥伴Bharat Biotech分享了COVAXIN的3期中期結果，證明療效達81%。"
    }
  ]
}